Registeranalysis for the Examination of NOMI (IRRE NOMI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02901808|
Recruitment Status : Unknown
Verified October 2017 by Peter Minko, Saarland University.
Recruitment status was: Active, not recruiting
First Posted : September 15, 2016
Last Update Posted : October 4, 2017
|Condition or disease|
All data were acquired from the hospital electronic health record and the picture archiving computer system (PACS).
NOMI was suspected if the following clinical signs occured:
new onset of oliguria (urine output <0.5 mL/kg/hour for at least 6 hours) or anuria, abdominal distention with decreased or absent bowel sounds, elevated serum lactate levels >5.0mmol/L or metabolic acidosis (base excess <-5mmol/L).
In accordance to the definition of cardiogenic shock angiography was performed in patients with a systolic blood pressure >90 mmHg and a cardiac index >1.8 L/minute/m².
|Study Type :||Observational|
|Actual Enrollment :||10000 participants|
|Official Title:||Interdisciplinary Retrospective Registeranalysis for the Examination of Non-occlusive Mesenteric Ischemia (NOMI)|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||December 2014|
|Estimated Study Completion Date :||December 2017|
Patients suffering from NOMI
Patients not suffering from NOMI
- Development of NOMI [ Time Frame: at the day of surgery, day zero ]Clinical signs of NOMI
- Length of stay [ Time Frame: at the day of surgery, day zero up to 365 days ]Length of stay will be measured upon the time spent on intensive care unit and in the hospital
- Mechanical ventilation [ Time Frame: at the day of surgery, day zero up to 365 days ]Length of mechanical ventilation will be measured upon the time spent on intensive care unit
- Mortality [ Time Frame: at the day of surgery, day zero up to 365 days ]Mortality will be measured upon patients leaving the hospital dead or alive.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02901808
|Saarland University Medical Center|
|Homburg, Saarland, Germany, 66421|
|Study Director:||Arno Buecker, MD||Department of Diagnostic and Interventional Radiology|
|Study Director:||Hans-Joachim Schäfers, MD||Department of Thoracic and Cardiovascular Surgery|